From the HRSA HIV/AIDS Bureau Update: Special Bulletin - 10/26/21
On Thursday, October 21, the Centers for Disease Control and Prevention (CDC) recommended a booster shot of the Moderna and Janssen (Johnson & Johnson) COVID-19 vaccines in certain populations.
These recommendations align with and follow the Food and Drug Administration’s (FDA) authorization of:
- The use of Moderna's COVID-19 vaccine to be administered as a booster for certain populations.
- The Janssen (Johnson & Johnson) COVID-19 vaccine for anyone 18 years and older who received that vaccine at least two months ago.
- The use of all three available COVID-19 vaccines (Moderna, Janssen (Johnson & Johnson), and Pfizer-BioNTech) as “mix and match” boosters for people who have completed their primary vaccination.
The guidelines for COVID-19 boosters vary by vaccine. However, people with HIV who are aged 18 years and older are included as those eligible.
The following resources are available to help Ryan White HIV/AIDS Program health care team members and clinicians understand what this means and assess readiness:
- Updated CDC COVID-19 Vaccine Booster Shot Webpage
- COVID-19 Vaccine Booster Planning Checklist for Health Centers – HRSA collaborated with CDC to create this checklist for health centers with information and tips for boosters, including resources to stay connected, readiness reminders, guidance on vaccine supply and administration, and more.
The following upcoming opportunity can also help Ryan White HIV/AIDS Program health care team members and clinicians learn more:
- Thursday, November 18, 2:00-3:00 PM ET - November HAB You Heard Webinar: Join HRSA’s HIV/AIDS Bureau for our monthly update. This meeting is open to RWHAP recipients, subrecipients, stakeholders, and federal staff and will include updated information about COVID-19 boosters for people with HIV. Register to participate in this session.